.
ResMed Inc (ASX:RMD) earned $73 million in the fourth quarter ended June 30.
The maker of devices for sleep-disordered breathing, ResMed says it had record revenue for the quarter of $414.6 million - 11 per cent more than the same quarter last year.
For the year ended June 30, 2013, net income was $307.1 million, an increase of 21 percent over the previous year.
The company says fourth quarter net income was reduced by a $17.7 million charge for settling litigation with the University of Sydney.
CEO Mick Farrell says the quarterly dividend has increased 47 per cent to 25 cents per share.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$41.25 |
Change
0.120(0.29%) |
Mkt cap ! $23.89B | |||
| Open | High | Low | Value | Volume |
| $41.47 | $41.47 | $41.23 | $34.47M | 834.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 89 | $41.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $41.50 | 1500 | 2 |
View Market Depth
| Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
| RMD (ASX) Chart |